身体成分与非透析依赖慢性肾脏病患者的临床结局相关
这项前瞻性队列研究纳入326例未透析的3-5期慢性肾脏病患者,用多频生物阻抗光谱设备测定瘦组织和脂肪组织指数。中位随访4.6年间发生40例死亡和68例心血管事件,高瘦组织指数而非高BMI或高脂肪组织指数预测复合结局风险更低。高瘦/高脂组织指数组复合结局风险显著更低(HR 0.36,95%CI 0.14-0.87)。
要点
- 高瘦组织指数预测非透析CKD患者死亡或心血管事件复合结局风险更低。
- 高BMI或高脂肪组织指数未显示与复合结局风险降低相关。
- 高瘦/高脂组织指数组复合结局风险显著低于低瘦/低脂组(HR 0.36)。
核心结论
- 瘦组织指数比单纯BMI能更好地预测非透析依赖CKD患者的风险。
- 高瘦/高脂组织指数与最佳结局相关。
研究设计与样本
- 前瞻性队列研究,纳入326例未透析的3-5期慢性肾脏病患者。
- 使用Body Composition Monitor多频生物阻抗光谱设备测定瘦组织和脂肪组织指数。
- 按BMI、瘦组织指数、脂肪组织指数中位数分为高/低组,并进一步分为四种身体成分组合。
主要发现
- 中位随访4.6年,发生40例死亡和68例心血管事件。
- Cox比例风险模型中,高瘦组织指数(参考:低于中位数)预测复合结局及其组分结局风险更低。
- 高BMI或高脂肪组织指数未预测复合结局风险降低。
- 高瘦/高脂组织指数组复合结局风险显著低于低瘦/低脂组(HR 0.36,95%CI 0.14-0.87)。
临床怎么用
- 在非透析依赖CKD患者中,可考虑用瘦组织指数辅助风险分层,而非仅依赖BMI。
- 高瘦/高脂组织指数可能提示较好预后,但需进一步确定改善CKD预后的最佳身体成分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An inverse relationship between body mass index (BMI) and mortality (the obesity paradox) has been found in patients with non-dialysis-dependent chronic kidney disease (CKD). However, it is unclear whether increased muscle mass or body fat confers the survival advantage. To resolve this we investigated the impact of body makeup on a composite outcome of death or cardiovascular events in a prospective cohort of 326 patients with stage 3-5 CKD not yet on dialysis. Lean mass and body fat were determined using the Body Composition Monitor, a multifrequency bioimpedance spectroscopy device, and were expressed as the lean tissue or fat tissue index, respectively. Patients were stratified as High (above median) or Low (below median) BMI, High or Low lean tissue index, or as High or Low fat tissue index. During a median follow-up of 4.6 years, there were 40 deaths and 68 cardiovascular events. In Cox proportional hazards models, a High lean tissue index, but not High BMI or High fat tissue index, predicted a lower risk of both the composite or its component outcomes (reference: below median). When patients were further stratified into four distinct body composition groups based on both the lean and fat tissue index, only the High lean/fat tissue index group had a significantly lower risk of the composite outcome (hazard ratio 0.36, 95% confidence interval 0.14-0.87; reference: Low lean/fat tissue index group). Thus, the lean tissue index can provide better risk prediction than the BMI alone in non-dialysis-dependent patients with CKD. The High lean/fat tissue index appears to be associated with best outcomes. An optimal body composition for improving the prognosis of CKD needs to be determined.
引用
- Lin TY, Peng CH, Hung SC, et al. Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease. Kidney Int. 2018. PMID: 29102374. doi:10.1016/j.kint.2017.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。